Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER⁺ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast Cancer
睾酮增强疗法可降低PIK3CA突变/ER⁺乳腺癌的发病率，但对BRCA1相关三阴性乳腺癌无影响。
期刊:
影响因子:
doi:10.1101/2025.09.15.25335324
Wang, Lin; Sardella, Brian R; Thavamani, Abhishek; Massicott, Erica S; Bret-Mounet, Vanessa C; Baker, Gabrielle M; Guzman-Arocho, Yaileen D; Tobias, Adam M; Bartlett, Richard A; Aronson, Emily K; Vandal, Steven R; Liu, Zhaoji; Lee, Jonah; Veta, Mitko; Wetstein, Suzanne C; Aung, Sai Tun Hein; Lui, Michelle L; Cato, Kenrick; Rohde, Christine H; Gardner, Kevin L; Hibshoosh, Hanina; Bockting, Walter O; Houghton, Lauren C; Charlton, Brittany M; Berwick, Shana A; Smart, Alicia C; Tesch, Megan E; Medford, Arielle J; Peterson, Cornelia W; Domogauer, Jason D; Jia, Li; Clohessy, John G; Tung, Nadine M; Wulf, Gerburg M; Heng, Yujing J
